Timothy Anderson

2 months ago | jamanetwork.com | Michael Incze |Timothy Anderson |William Becker |Karen H Seal

Integrating Buprenorphine Into Chronic Pain Treatment—Putting the Choice in VOICE Buprenorphine, Pain, and Opioid Use in Patients Taking High-Dose Long-Term Opioids William C. Becker, MD; Karen H. Seal, MD, MPH; David B. Nelson, PhD; Beth M. DeRonne, PharmD; Allyson M. Kats, MS; Benjamin J. Morasco, PhD; Joseph W. Frank, MD, MPH; Una E. Makris, MD, MSc; Jacob T. Painter, PharmD, MBA, PhD; Kelli D. Allen, PhD; Amanda S. Mixon, MD, MS, MSPH; Amy Bohnert, PhD; Thomas E.

2 months ago | healio.com | Scott Buzby |Richard Smith |Timothy Anderson

Certain low-risk populations continue baby aspirin use, despite risk and clinical guidance• Some Asian, Black and Mexican American adults at low ASCVD risk continue taking baby aspirin, despite risk and clinical guidance. • Similar observations were reported for those on Medicaid or without insurance.

Nov 25, 2024 | jamanetwork.com | Lily G Bessette |Timothy Anderson

Generalizability of Clinical Trials of Novel Weight Loss Medications to the US Adult Population Glucagon-like peptide 1 (GLP-1) receptor agonists liraglutide and semaglutide and dual GLP-1 and glucose-dependent insulinotropic polypeptide (GLP-1/GIP) receptor agonist tirzepatide are novel treatments for weight loss.

Sep 3, 2024 | jamanetwork.com | Timothy Anderson |Deborah Grady

Glucagon-Like Peptide-1 Receptor Agonists and Suicidality—Two Important Pieces of Data but an Incomplete Puzzle GLP-1 Receptor Agonist Use and Risk of Suicide Death Peter Ueda, MD, PhD; Jonas Söderling, PhD; Viktor Wintzell, PhD; Henrik Svanström, PhD; Laura Pazzagli, PhD; Björn Eliasson, MD, PhD; Mads Melbye, MD, DrMedSci; Anders Hviid, DrMedSci; Björn Pasternak, MD, PhD Psychiatric Safety of Semaglutide for Weight Management in People Without Known Major Psychopathology Thomas A. Wadden,...

Aug 6, 2024 | healio.com | Scott Buzby |Richard Smith |Timothy Anderson

You've successfully added Practice Management in Cardiology to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways:Follow-up care after CV events rose, but gaps remain for Black and Medicaid dual-eligible patients.